Overview
Nichola Johnson practices practicing medicine in London, United Kingdom.
Ms. Johnson is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Breast Cancer, Menopause, and Ovarian Cancer.
She is actively involved in clinical research, co-authoring 69 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nichola I. Johnson
Is Nichola I. Johnson a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Nichola I. Johnson is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nichola I. Johnson participate in research or clinical trials?
Yes. Nichola I. Johnson has published 67 articles and abstracts on conditions like Breast Cancer. You can view a list of Nichola I. Johnson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerMs. Johnson isAdvanced. Learn about Breast Cancer.
- Experienced
- MenopauseMs. Johnson isExperienced. Learn about Menopause.
- Ovarian CancerMs. Johnson isExperienced. Learn about Ovarian Cancer.